PL355470A1 - Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawanialeku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego - Google Patents
Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawanialeku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowegoInfo
- Publication number
- PL355470A1 PL355470A1 PL02355470A PL35547002A PL355470A1 PL 355470 A1 PL355470 A1 PL 355470A1 PL 02355470 A PL02355470 A PL 02355470A PL 35547002 A PL35547002 A PL 35547002A PL 355470 A1 PL355470 A1 PL 355470A1
- Authority
- PL
- Poland
- Prior art keywords
- expected
- place
- application
- active substance
- equipment designed
- Prior art date
Links
- 101500007657 Crotalus durissus terrificus Crotoxin chain gamma Proteins 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000980 1H-indol-3-ylmethyl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[*])C2=C1[H] 0.000 abstract 1
- DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical group OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical group OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 abstract 1
- 229930195711 D-Serine Chemical group 0.000 abstract 1
- 125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 229930182846 D-asparagine Chemical group 0.000 abstract 1
- 125000003643 D-glutamine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C([H])([H])C(N([H])[H])=O 0.000 abstract 1
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical group CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 1
- 229930182819 D-leucine Chemical group 0.000 abstract 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical group CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 abstract 1
- 229930182818 D-methionine Chemical group 0.000 abstract 1
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical group C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 abstract 1
- 229930182822 D-threonine Chemical group 0.000 abstract 1
- 239000000203 mixture Chemical group 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL355470A PL205811B1 (pl) | 2002-08-13 | 2002-08-13 | Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawania leku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego |
| US10/524,343 US8084429B2 (en) | 2002-08-13 | 2003-08-07 | Compounds and their analgesic applications |
| DE60320999T DE60320999D1 (de) | 2002-08-13 | 2003-08-07 | Derivate von biphalin und deren verwendung als analgetika |
| PT03754322T PT1529057E (pt) | 2002-08-13 | 2003-08-07 | Derivados da bifalina e suas aplicações analgésicas |
| AT03754322T ATE395354T1 (de) | 2002-08-13 | 2003-08-07 | Derivate von biphalin und deren verwendung als analgetika |
| EP03754322A EP1529057B1 (en) | 2002-08-13 | 2003-08-07 | Biphalin derivatives and their analgesic applications |
| DK03754322T DK1529057T3 (da) | 2002-08-13 | 2003-08-07 | Derivat af biphalin og anvendelse heraf som analgetikum |
| SI200331288T SI1529057T1 (sl) | 2002-08-13 | 2003-08-07 | Derivati bifalina in analgetska uporaba le-teh |
| PCT/PL2003/000077 WO2004014943A2 (en) | 2002-08-13 | 2003-08-07 | Biphalin derivates and their analgesic applications |
| ES03754322T ES2306885T3 (es) | 2002-08-13 | 2003-08-07 | Derivados de bifalina y sus aplicaciones analgesicas. |
| AU2003272160A AU2003272160A1 (en) | 2002-08-13 | 2003-08-07 | Biphalin derivates and their analgesic applications |
| CY20081100862T CY1110890T1 (el) | 2002-08-13 | 2008-08-13 | Παραγωγα διφαλινης και οι αναλγητικες τους εφαρμογες |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL355470A PL205811B1 (pl) | 2002-08-13 | 2002-08-13 | Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawania leku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL355470A1 true PL355470A1 (pl) | 2004-02-23 |
| PL205811B1 PL205811B1 (pl) | 2010-05-31 |
Family
ID=31713224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL355470A PL205811B1 (pl) | 2002-08-13 | 2002-08-13 | Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawania leku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8084429B2 (pl) |
| EP (1) | EP1529057B1 (pl) |
| AT (1) | ATE395354T1 (pl) |
| AU (1) | AU2003272160A1 (pl) |
| CY (1) | CY1110890T1 (pl) |
| DE (1) | DE60320999D1 (pl) |
| DK (1) | DK1529057T3 (pl) |
| ES (1) | ES2306885T3 (pl) |
| PL (1) | PL205811B1 (pl) |
| PT (1) | PT1529057E (pl) |
| SI (1) | SI1529057T1 (pl) |
| WO (1) | WO2004014943A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8026218B2 (en) * | 2006-04-26 | 2011-09-27 | The University Of Arizona | Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists |
| PL381925A1 (pl) * | 2007-03-07 | 2008-09-15 | Andrzej W. Lipkowski | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
| PL208164B1 (pl) * | 2007-09-24 | 2011-03-31 | Inst Medycyny Doświadczalnej I Klinicznej Pan Im M Mossakowskiego | Nowe peptydowe kompleksy platyny, sposób ich otrzymywania, kompozycja farmaceutyczna i zastosowanie |
| WO2010033240A2 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| HRP20130463T1 (en) * | 2008-12-31 | 2013-07-31 | Action For Development Of Research Sp. Z O.O. | A method of producing a novel opioid peptide |
| WO2015127451A1 (en) | 2014-02-24 | 2015-08-27 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Multivalent/multifunctional ligands with agonist activities at opioid receptors and antagonist activities at nk1 receptor for relief of pain |
| PL422093A1 (pl) * | 2017-07-03 | 2019-01-14 | Uniwersytet Warszawski | Nowe peptydomimetyki hybrydowe do zastosowań w bólu neuropatycznym |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2032226A1 (en) * | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepine analogs |
| US5356902A (en) * | 1992-11-06 | 1994-10-18 | Eli Lilly And Company | Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists |
| GB9426102D0 (en) * | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Pharmacuetical compositions |
-
2002
- 2002-08-13 PL PL355470A patent/PL205811B1/pl unknown
-
2003
- 2003-08-07 DE DE60320999T patent/DE60320999D1/de not_active Expired - Lifetime
- 2003-08-07 AU AU2003272160A patent/AU2003272160A1/en not_active Abandoned
- 2003-08-07 WO PCT/PL2003/000077 patent/WO2004014943A2/en not_active Ceased
- 2003-08-07 PT PT03754322T patent/PT1529057E/pt unknown
- 2003-08-07 AT AT03754322T patent/ATE395354T1/de active
- 2003-08-07 SI SI200331288T patent/SI1529057T1/sl unknown
- 2003-08-07 ES ES03754322T patent/ES2306885T3/es not_active Expired - Lifetime
- 2003-08-07 EP EP03754322A patent/EP1529057B1/en not_active Expired - Lifetime
- 2003-08-07 DK DK03754322T patent/DK1529057T3/da active
- 2003-08-07 US US10/524,343 patent/US8084429B2/en not_active Expired - Fee Related
-
2008
- 2008-08-13 CY CY20081100862T patent/CY1110890T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004014943A3 (en) | 2004-04-29 |
| AU2003272160A8 (en) | 2004-02-25 |
| US20060241053A1 (en) | 2006-10-26 |
| DK1529057T3 (da) | 2008-09-08 |
| EP1529057A2 (en) | 2005-05-11 |
| WO2004014943A2 (en) | 2004-02-19 |
| PL205811B1 (pl) | 2010-05-31 |
| AU2003272160A1 (en) | 2004-02-25 |
| ES2306885T3 (es) | 2008-11-16 |
| PT1529057E (pt) | 2008-08-26 |
| CY1110890T1 (el) | 2015-06-10 |
| EP1529057B1 (en) | 2008-05-14 |
| DE60320999D1 (de) | 2008-06-26 |
| SI1529057T1 (sl) | 2008-10-31 |
| US8084429B2 (en) | 2011-12-27 |
| ATE395354T1 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004007679A3 (en) | Dendritic cell pontentiation | |
| WO2004070772A3 (de) | Carbazol-enthaltende konjugierte polymere und blends, deren darstellung und verwendung | |
| AU2003249539A1 (en) | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors | |
| SI2325302T1 (sl) | Celice, ki soizražajo sulfatazo in c-formilglicin generirajoči encim ter postopki in uporabe le-teh | |
| IL164509A0 (en) | Furyl compounds | |
| AU2003272275A1 (en) | Organic species that facilitate charge transfer to or from nanostructures | |
| DE60331319D1 (de) | Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen | |
| PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
| TW200619183A (en) | New compound and organic light-emitting device using the same (1) | |
| GEP20084539B (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain | |
| AU2003206734A1 (en) | Dermal application system for aminolevulinic acid-derivatives | |
| IL164613A0 (en) | Thienyl compounds | |
| TW200736263A (en) | Compounds | |
| PL355470A1 (pl) | Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawanialeku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego | |
| MX2009012203A (es) | Tratamiento de distrofia muscular de duchenne. | |
| TW200801001A (en) | Compounds | |
| AU2003216579A1 (en) | Imidazole compounds as anti-inflammatory and analgesic agents | |
| AU2002212894A1 (en) | N-type calcium channel antagonists for the treatment of pain | |
| TW200706637A (en) | Imidazole derivatives and organic electronic device using the same | |
| TW200730513A (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
| AU2003294253A1 (en) | Emulsions including surface-modified organic molecules | |
| SE0203302D0 (sv) | Novel Compounds | |
| EP1697431B8 (en) | Boron-containing polymer compound and organic light emitting device using the same | |
| DE60236025D1 (de) | Pharmazeutische zusammensetzung enthaltend l-arginin | |
| AU2003218670A1 (en) | Derivatives of azaspiro compounds for the treatment of pain |